Digital healthcare firm Trellus Health faces a race to secure fresh funding and stay afloat, despite extending its cash runway until early December 2025. The AIM-listed company, which operates the Trellus Elevate digital platform to help patients manage chronic conditions such as inflammatory bowel disease, said it held $1.6 million in cash at the end … Continue reading AIM-listed HealthTech on borrowed time as cash runway extended